Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues        
License and other revenues $ 7,000,000 $ 7,000,000
Expenses:        
Research and development 7,969,000 10,917,000 20,896,000 38,961,000
General and administrative 4,432,000 4,700,000 16,382,000 15,971,000
Depreciation and amortization 847,000 2,032,000 3,746,000 5,747,000
Licensed technology impairment charge 32,916,000
Total expenses 13,248,000 17,649,000 73,940,000 60,679,000
Loss from operations (6,248,000) (17,649,000) (66,940,000) (60,679,000)
Interest and miscellaneous income 338,000 277,000 1,261,000 828,000
Interest and other expense (1,327,000) (2,727,000)
Net loss $ (7,237,000) $ (17,372,000) $ (68,406,000) $ (59,851,000)
Basic and diluted loss per common share $ (0.08) $ (0.35) $ (0.73) $ (1.22)
Weighted average number of common shares outstanding – basic and diluted 93,772,712 49,721,753 93,199,679 48,883,883
Other comprehensive income/(loss):        
Change in unrealized (losses) gains related to available-for-sale debt securities $ (116,000) $ 17,000
Comprehensive loss $ (7,353,000) $ (17,372,000) $ (68,389,000) $ (59,851,000)